These findings confirm that englerin is a TRPC4 agonist, which suppresses tumor cell proliferation, but the mechanism by which TRPC4 channel agonism leads to growth inhibition in tumor cell lines is not known. The gene discussed is TRPC4; the disease is neoplasm.